These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 622119)

  • 1. Seroconversion from hepatitis B e antigen to anti-HBe in acute hepatitis B virus infection.
    Aikawa T; Sairenji H; Furuta S; Kiyosawa K; Shikata T; Imai M; Miyakawa Y; Yanase Y; Mayumi M
    N Engl J Med; 1978 Feb; 298(8):439-41. PubMed ID: 622119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG
    Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antigens and antibodies in acute viral hepatitis caused by the B virus. Clinical significance].
    Malacco E; Iacono G; Risso F
    Minerva Med; 1979 Feb; 70(6):479-82. PubMed ID: 431867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Markers of type B viral hepatitis].
    Brunello F; Emanuelli G; Camussi G
    Minerva Med; 1979 Sep; 70(41):2791-800. PubMed ID: 386166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R; Rabagliati AM
    G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].
    Turci F; Iosa G; Cipolloni A; Cenciotti L
    Quad Sclavo Diagn; 1980 Dec; 16(4):349-55. PubMed ID: 7244108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.
    Realdi G; Alberti A; Rugge M; Bortolotti F; Rigoli AM; Tremolada F; Ruol A
    Gastroenterology; 1980 Aug; 79(2):195-9. PubMed ID: 7399226
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
    Babeş VT; Cepănaru S; Cepănaru R; Tănase M
    Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HBe Ag/anti-HBe system: results of a study of 66 patients having the hepatitis B surface antigen (HBsAG)].
    Lemaire JM; Borgeot C; Mourrut C; Michel H
    Nouv Presse Med; 1978 Sep; 7(32):2878. PubMed ID: 714681
    [No Abstract]   [Full Text] [Related]  

  • 14. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
    Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of occurrence of HBeAg and anti-HBe among blood donors and patients with liver diseases in Tamil Nadu.
    Thyagarajan SP; Subramaniam S; Solomon S; Panchanadam M; Madanagopalan N
    Indian J Med Res; 1980 Feb; 71():309-15. PubMed ID: 7380507
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risk of development of hepatitis B virus infection among alcoholics].
    Boroń P; Bobrowska E; Borzuchowska A; Boroń-Kaczmarska A; Flisiak R; Grzeszczuk A; Prokopowicz D
    Przegl Epidemiol; 1991; 45(4):291-5. PubMed ID: 1841404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The virus of hepatitis, type B. (Second of two parts).
    Robinson WS; Lutwick LI
    N Engl J Med; 1976 Nov; 295(22):1232-6. PubMed ID: 790185
    [No Abstract]   [Full Text] [Related]  

  • 19. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.